Cargando…
Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study
OBJECTIVES: To analyse variation in clinical management of cT1 renal cell carcinoma (RCC) in the Netherlands related to surgical hospital volume (HV). MATERIALS AND METHODS: Patients diagnosed with cT1 RCC during 2014–2020 were identified in the Netherlands Cancer Registry. Patient and tumour charac...
Autores principales: | Yildirim, H., Schuurman, M. S., Widdershoven, C. V., Lagerveld, B. W., van den Brink, L., Ruiter, A. E. C., Beerlage, H. P., van Moorselaar, R. J. A., Graafland, N. M., Bex, A., Aben, K. K. H., Zondervan, P. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268570/ https://www.ncbi.nlm.nih.gov/pubmed/37334025 http://dx.doi.org/10.1002/bco2.229 |
Ejemplares similares
-
Laparoscopic cryoablation for small renal masses: Oncological outcomes at 5-year follow-up
por: Henderickx, Michaël M.E.L., et al.
Publicado: (2020) -
Impact of the COVID-19 pandemic on kidney cancer care in the Netherlands
por: Yildirim, H., et al.
Publicado: (2022) -
Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-up
por: Widdershoven, Christiaan V., et al.
Publicado: (2020) -
Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?
por: Fransen van de Putte, Elisabeth E., et al.
Publicado: (2023) -
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs
por: Yildirim, Hilin, et al.
Publicado: (2023)